Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Susan Laura Smith Insider Profile
4 Followers
Susan Laura Smith, SVP & CCO at Y-Mabs Therapeutics, holds 33.92K shares in Y-Mabs Therapeutics (Ticker: YMAB). Most recently, Susan Laura Smith Sold $1,682 shares of Y-Mabs Therapeutics on Mar 07, 2024 for an estimated value of 27.84K.
Susan Laura Smith has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Susan Laura Smith's holdings
Insider Roles
SVP & CCO
Roles that Susan Laura Smith holds in companies
Most Profitable Insider Trade
The most profitable trade made by Susan Laura Smith
Susan Laura Smith's Trading History
List of latest transactions for each holding click on a transaction to see Susan Laura Smith's performance on stock
You May Also Like
Susan Laura Smith insider profile FAQ
What is the percentage of profitable transactions made by Susan Laura Smith?
The percentage of profitable transactions made by Susan Laura Smith is ―.
What is the average return per transaction made by Susan Laura Smith?
The average return per transaction made by Susan Laura Smith is ―.
What stocks does Susan Laura Smith hold?
Susan Laura Smith holds: YMAB stocks.
What was Susan Laura Smith’s latest transaction?
Susan Laura Smith latest transaction was an Informative Sell of $27.84K.
What was Susan Laura Smith's most profitable transaction?
Susan Laura Smith’s most profitable transaction was an Informative Sell of YMAB stock on March 7, 2024. The return on the trade was 14.20%.
What is Susan Laura Smith's role in Y-Mabs Therapeutics?
Susan Laura Smith's role in Y-Mabs Therapeutics is SVP & CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.